M Shimura, T Nakazawa, K Yasuda, T Shiono, … - American journal of ophthalmology, 2008 - Elsevier Before the injection, foveal thickness and VA were 522.3 ± 91.3 μm and 0.64 ±
0.28 μm in the triamcinolone-injected eye, and 527.6 ± 78.8 μm and 0.61 ±
0.18 μm in the bevacizumab-injected eye, respectively; there was no ... Cited by 36 - Related articles - All 34 versions
M Shimura, T Nakazawa, K Yasuda, T Shiono, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: 42 eyes of 37 consecutive patients with DDME were studied. 1 week
before G-PC, 21 eyes received TA subtenon injection, and the other eyes served
as control. The clinical course of visual acuity (VA) and foveal thickness ... Cited by 12 - Related articles - BL Direct - All 4 versions
- ►psu.edu [PDF] M Kisilevsky, C Hudson, JG Flanagan, RK … - Archives of Ophthalmology, 2006 - Am Med Assoc Objectives To estimate the agreement between the macular edema maps (MEMs) of
the Retina Module of the Heidelberg Retina Tomograph II (Heidelberg Engineering,
Heidelberg, Germany) and contact lens fundus biomicroscopy (FB) and to ... Cited by 11 - Related articles - BL Direct - All 6 versions
MB Parodi, S Spasse, P Iacono, G Di Stefano, … - Ophthalmology, 2006 - Elsevier To compare the effectiveness of subthreshold grid laser treatment (SGLT) with an
infrared micropulse diode laser with that of threshold grid laser treatment
(TGLT) for macular edema secondary to branch retinal vein occlusion (BRVO). Cited by 11 - Related articles - All 20 versions
F Sobha Sivaprasad, RS MRCOphth, AT … - Clinical & Experimental Ophthalmology - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►stanford.edu [PDF] AT Jain, MS Blumenkranz, Y Paulus, MW … - Archives of Ophthalmology, 2008 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 9 - Related articles - BL Direct - All 7 versions
JK Luttrull, DC Musch, CA Spink - Eye, 2007 - nature.com A retrospective chart review of all patients undergoing PRP for diabetic
retinopathy between April 2000 and February 2003 was performed. Treated
conditions ranged from severe non-proliferative to severe proliferative ... Cited by 8 - Related articles - BL Direct - All 3 versions
AS Neubauer, MW Ulbig - Ophthalmologica, 2007 - content.karger.com Diabetic retinopathy is a leading cause of visual impairment and blindness in
developed countries due to macular edema and proliferative diabetic retinopathy
(PDR). For both complications laser treatment may offer proven therapy: the ... Cited by 9 - Related articles - BL Direct - All 4 versions
G Lang - Developments in ophthalmology, 2007 - content.karger.com Abstract Laser treatment of diabetic retinopathy is still the gold standard of
treatment for focal and diffuse diabetic macular edema and proliferative
diabetic retinopathy. When properly treated, the 5-year risk of blindness ... Cited by 7 - Related articles - BL Direct - All 5 versions
T Iida - British Journal of Ophthalmology, 2007 - bjo.bmj.com Diabetic macular oedema is a major cause of visual loss in patients with
diabetes. The Early Treatment of Diabetic Retinopathy Study showed that focal
laser photocoagulation reduced moderate visual loss in eyes with clinically ... Cited by 4 - Related articles - BL Direct - All 4 versions
